California Public Employees Retirement System
BTAI icon

California Public Employees Retirement System’s BioXcel Therapeutics BTAI Stock Holding History

California Public Employees Retirement System’s Portfolio BTAI Stock Details BTAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,488
Closed -$1.03M – 1754
2021
Q1 		$1.03M Sell
1,488
-202
-12% -$162K ﹤0.01% 2480
2020
Q4 		$1.25M Sell
1,690
-17
-1% -$13.2K ﹤0.01% 2322
2020
Q3 		$1.18M Buy
1,707
+196
+13% +$147K ﹤0.01% 2154
2020
Q2 		$1.28M Sell
1,511
-4,960
-77% -$3.23M ﹤0.01% 2061
2020
Q1 		$2.31M Sell
6,471
-13,260
-67% -$4.77M ﹤0.01% 1522
2019
Q4 		$4.61M Hold
19,731
– – ﹤0.01% 1510
2019
Q3 		$2.22M Buy
19,731
+1,081
+6% +$171K ﹤0.01% 1820
2019
Q2 		$3.27M Hold
18,650
– – ﹤0.01% 1384
2019
Q1 		$2.95M Hold
18,650
– – ﹤0.01% 1514
2018
Q4 		$1.15M Hold
18,650
– – ﹤0.01% 2099
2018
Q3 		$2.29M Hold
18,650
– – ﹤0.01% 1825
2018
Q2 		$2.75M Sell
18,650
-1,869
-9% -$285K ﹤0.01% 1693
2018
Q1 		$3.36M Buy
+20,519
New +$3.43M ﹤0.01% 1559

Other funds holding BTAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return

California Public Employees Retirement System's BTAI Position: Q2 2021 in Review

California Public Employees Retirement System sold out of BioXcel Therapeutics (BTAI) in Q2 2021, closing a stake of 1,488 shares — an estimated $1.03M sold.

California Public Employees Retirement System first reported a position in BTAI in Q1 2018 and held it in 13 quarters. The position peaked at $4.61M in Q4 2019. 108 funds tracked by Wall St. Rank hold BTAI as of Q2 2021.

  • California Public Employees Retirement System reported no remaining BioXcel Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 1,488 BioXcel Therapeutics shares in Q2 2021, an estimated $1.03M.
  • California Public Employees Retirement System first reported a position in BioXcel Therapeutics in Q1 2018 and held it in 13 quarters.
  • California Public Employees Retirement System's BioXcel Therapeutics position peaked at $4.61M in Q4 2019.
  • 108 funds tracked by Wall St. Rank held BioXcel Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.